Summary
- Current Price
- As of today, ACRS price is $5.78, down -2.20% in the most recent trading session on
- Current Price All-Time High
- ACRS price is currently -82.94% below its historical high of $33.88 set on
- Market Cap
- ACRS current market cap is $849M, up +381.07% over the past 365 days
- Revenue
- ACRS current annual revenue is $7.83M, down -58.19% year-over-year
- Next Earnings
- The next earnings release for ACRS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Aclaris Therapeutics, Inc. |
| Ticker | NASDAQ: ACRS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | aclaristx.com |
| Employees | 61 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $5.78 | |
| Price, 1D Change | -2.20% | |
| $849M | ||
| - | ||
| - | ||
| 0.62 | ||
| $7.83M | ||
| Revenue, 1Y Change | -58.19% | |
| -$0.53 | ||
| EPS, 1Y Change | +69.00% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.53 | ||
| EPS Estimate | -$0.65 | N/A |
| EPS Est. Change | -22.48% | N/A |
| $7.83M | ||
| Revenue Estimate | $5.85M | N/A |
| Revenue Est. Change | -25.22% | N/A |
| Current Price | $5.78 | |
| Price Target | $10.00 | - |
| Price Tgt. Change | +73.01% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.93 | -$1.71 | -83.72% | |
| -$0.49 | -$0.53 | -7.38% | |
| -$0.65 | N/A | -22.48% | |
| -$0.82 | N/A | -55.64% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $16.54M | $18.72M | +13.15% | |
| $7.99M | $7.83M | -2.07% | |
| $5.85M | N/A | -25.22% | |
| $5.36M | N/A | -31.53% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $5.78 | |
| $3.84 | ||
| $5.11 | ||
| $4.03 | ||
| $5.22 | ||
| $0.21 | ||
| 0.62 | ||
| $0.38 | ||
| 58.10 | ||
| 74.78% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $7.83M | ||
| -$0.53 | ||
| $542.00K | ||
| 6.93% | ||
| -$74.08M | ||
| -943.97% | ||
| -$64.92M | ||
| -829.58% | ||
| -$73.62M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 3.36 | ||
| 3.36 | ||
| - | ||
| 3 | ||
| -0.53 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 103.35 | ||
| 6.82 | ||
| -8.94 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $103.08M | ||
| $151.36M | ||
| $160.46M | ||
| $96.32M | ||
| $57.38M | ||
| $28.65M | ||
| $2.12M | ||
| $551.00K | ||
| $13.16M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $72.75M | ||
| $74.62M | ||
| $7.28M | ||
| $21.97M | ||
| $454.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$47.11M | ||
| $48.37M | ||
| -$5.86M | ||
| $111.00K | ||
| -$47.22M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| LifeSci Capital | ||
| Piper Sandler | → | |
| Guggenheim | ||
| Wedbush | → | |
| Oppenheimer | ||
| Wedbush | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
No data
Screeners with ACRS
FAQ
- What is the ticker symbol for Aclaris Therapeutics, Inc.?
- The ticker symbol for Aclaris Therapeutics, Inc. is NASDAQ:ACRS
- Does Aclaris Therapeutics, Inc. pay dividends?
- No, Aclaris Therapeutics, Inc. does not pay dividends
- What sector is Aclaris Therapeutics, Inc. in?
- Aclaris Therapeutics, Inc. is in the Healthcare sector
- What industry is Aclaris Therapeutics, Inc. in?
- Aclaris Therapeutics, Inc. is in the Biotechnology industry
- What country is Aclaris Therapeutics, Inc. based in?
- Aclaris Therapeutics, Inc. is headquartered in United States
- When did Aclaris Therapeutics, Inc. go public?
- Aclaris Therapeutics, Inc. initial public offering (IPO) was on October 6, 2015
- Is Aclaris Therapeutics, Inc. in the S&P 500?
- No, Aclaris Therapeutics, Inc. is not included in the S&P 500 index
- Is Aclaris Therapeutics, Inc. in the NASDAQ 100?
- No, Aclaris Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Aclaris Therapeutics, Inc. in the Dow Jones?
- No, Aclaris Therapeutics, Inc. is not included in the Dow Jones index
- When was Aclaris Therapeutics, Inc. last earnings report?
- Aclaris Therapeutics, Inc.'s most recent earnings report was on August 6, 2026
- When does Aclaris Therapeutics, Inc. report earnings?
- The next expected earnings date for Aclaris Therapeutics, Inc. is November 5, 2026
Data Sources & References
- ACRS Official Website www.aclaristx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1557746/000110465926020540/0001104659-26-020540-index.htm
- ACRS Profile on Yahoo Finance finance.yahoo.com/quote/ACRS
- ACRS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/acrs